DAY 1 - Tuesday, 14 May
INTEREST 2019
Related Enduring Materials
Enduring Materials
- 07:30
07:30
Registration Desk Open
08:00
Walk in Coffee / Tea
09:00
Welcome from the Conference Co-chairs
Kwasi Torpey, MD, PhD, MPH, FGCP - Local Chair
University of Ghana, Ghana
Elly Katabira, MD, FRCP - Co-Chair
Makerere University College of Health Sciences Uganda
Catherine Hankins, MD, PhD, FRCPC, CM - Scientific Chair
Amsterdam Institute for Global Health and Development, The Netherlands / Canada
Session 1: Official Opening Session -
Chairs
Elly Katabira, MD, FRCP
Makerere University College of Health Sciences Uganda
Kwasi Torpey, MD, PhD, MPH, FGCP
University of Ghana, Ghana
09:10
Welcome to Ghana
Honourable Kwaku Agyemang Manu
Minister of Health
09:25
The Road to 90-90-90: Progress in HIV Prevention and Treatment Scale-up in Sub-Saharan Africa
Karusa Kiragu, PhD
UNAIDS, Uganda
09:45
Current Status of HIV in Ghana
Kyeremeh Atuahene
Ghana AIDS Commission, Ghana
10:00
Community Perspective on Progress in Ghana
Cecilia Senoo
Hope for Future Generation, Ghana
10:15
Keynote Address
First Lady of Ghana Her Excellency Mrs Rebecca Akufo-Addo
-
10:30
Refreshment Break and Poster Viewing
Session 2: HIV Prevention: Who’s in, Who’s out and Who’s Shaking It All About? -
Chairs
Elizabeth Bukusi, MBChB, MMed, MPH, PhD, PGD, MBE
Kenya Medical Research Institute, Kenya
Catherine Hankins, MD, PhD, FRCPC, CM
Amsterdam Institute for Global Health and Development, The Netherlands / Canada
11:00
Is DREAMS Having an Impact on HIV Prevention in Young Women?
Ambassador Deborah Birx, MD
US Department of State, USA
11:25
Evolving Use of Oral PrEP (Lessons Learned) and Update on New Prevention Technologies – Rings, Long-acting Injectables, Implants
Sinead Delany-Moretlwe, MBBCh, PhD, DTM&H
The Wits Reproductive Health and HIV Institute (WRHI), University of the Witwatersrand, South Africa
11:50
What about the Men: Finding the Missing Connection
Daniel Were, PhD
Jhpiego, Kenya
12:15
Audience Q&A
12:30
Lunch and Early-career Investigator Meet-the-expert
Oral Abstract presentations -
Chairs
Sam Phiri
Malawi
Charles Boucher
The Netherlands
13:30
High Rate of PrEP Eligibility and Associated HIV Incidence in a Generalized Epidemic
Victor Ssempijja
#1
13:45
Dually Enacted Stigma among Young People and their Caregivers Living with HIV: Challenges and Opportunities to Reaching 90-90- 90 in Zambia
Joseph Gregory Rosen
#2
14:00
Implementing a National Mhealth System Improves Viral Suppression and Retention in Routine HIV Care in Kenya
Anthony Wachira
#3
14:15
Increasing Access to Antiretroviral Therapy; Lessons Learnt from Implementing Family Centered PMTCT Option B+ Services in 13 States in Nigeria
Ihoghosa Iyamu
#4
Session 3: Innovative Work with Key Populations in Africa -
Chairs
Stephen Ayisi Addo
Ghana
Timothy Mastro
USA
14:30
Progress in Engaging Key Populations in Africa
Christopher Akolo, MD, MSc, FWACP
FHI360, USA
14:55
Audience Q&A
15:00
Conference Photo
15:15
Refreshment Break and Poster Viewing
Session 4: Update on Hormonal Contraception and HIV Risk -
Chair
Linda-Gail Bekke
South Africa
15:45
Why the ECHO Trial and What Will It Tell Us?
Elizabeth Bukusi, MBChB, MMed, MPH, PhD, PGD, MBE
Kenya Medical Research Institute, Kenya
16:10
Audience Q&A
Session 5: Community Impact of Treatment -
Chair
James Hakim
Zimbabwe
16:15
PopART in Zambia and South Africa: What Have We Learned?
Albertus Schaap, MSc
London School of Hygiene and Tropical Medicine / Zambart, United Kingdom / Zambia
16:40
Audience Q&A
Session 6: Opening Day Formal Debate: The “U=U” Message is Not Appropriate for Africa -
Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD
Chair
Peter Kilmarx
USA
16:45
Opening Words
16:50
First Speaker for the Proposition
16:57
First Speaker against the Proposition
Desmond Tutu Health Foundation / University of Cape Town (UCT), South Africa
17:04
Debate from the Floor
17:29
Second Speaker for the Proposition
Tapiwanashe Kujinga, LLB
Pan-African Treatment Access Movement, Zimbabwe
17:33
Second Speaker against the Proposition
Lucy Wanjiku Njenga
Positive Young Women Voices, Kenya
17:37
Rebuttal
Each Team 2 Minutes
-
17:41
Voting
17:45
Opening Reception
DAY 2 - Wednesday, 15 May 2019
- 07:00
07:00
Parallel Early Morning Sessions: Grantspersonship, Joep Lange Career Guidance, and Themed Poster Discussions
Session 7: Update on HIV Vaccines and the Promise of a Cure -
Chairs
Isabella Akyinbah Quakyi
Ghana
Guido Ferrar
USA
08:00
HIV Vaccine Pipeline and Progress, Including Broadly Neutralizing Antibodies (BnAbs)
Glenda Gray, MBBCh, FCPaed(SA), DSc (Hons)
South African Medical Research Council, South Africa
08:25
Audience Q&A
08:30
Acute Infection and HIV Cure: Current Status and Implications for the Future
Zaza Ndhlovu, PhD
Africa Health Institute, SA/Zimbabwe
08:55
Audience Q&A
Oral Abstract Presentations II -
Chairs
James Hakim
Zimbabwe
Anna Laura Ross
Switzerland
09:00
Association Between Contraceptive Use and PrEP Uptake and Continuation in Adolescent Girls and Young Women in Cape Town, South Africa
Elzette Rousseau
#5
09:15
The Role of Executive Functioning in Medical Adherence: Evidence from the HIV Associated Neuro-Cognitive Disorders Study in Zambia
Sylvia Mwanza
#6
09:30
Sexually Transmitted Infections in MSM in West Africa: Incidence and Associated Factors (CohMSM ANRS 12324–Expertise France)
Issifou Yaya
#7
09:45
Alcohol Use, Aggressive Behaviours and Mental Health Status are Associated with All Identified Typologies of Risky Sexual Behaviours Among Adolescent Girls and Young Women (10-24 years) in Western Cape, South Africa
Joel Francis
#8
10:00
Refreshment Break and Poster Viewing
SYMPOSIUM I - Gilead: Viral Hepatitis C in Africa: Working Towards Elimination Goals -
Chair
Mark Sonderup
South Africa
10:30
Introduction: Objective and Goals Viral Hepatitis and Elimination Efforts Overview, African Perspective, WHO Goals, and Introduction to Elimination
Mark Sonderup
University of Cape Town, South Africa
10:40
Overview of Viral Hepatitis Elimination Efforts in Rwanda - Success Factors and Challenges
Emmanuel Musabeyezu
King Faisal Hospital, Rwanda
11:00
Overview of Viral Hepatitis Elimination Efforts in Egypt - Success Factors and Challenges
Imam Waked
Menoufiya University, Egypt
11:20
Viral Hepatitis Landscape in South Africa and Implementation Plans
Mark Sonderup
University of Cape Town, South Africa
11:40
Audience Q&A and Panel Discussion
11:50
Summary and Closure
Mark Sonderup
University of Cape Town, South Africa
Mini-Oral Abstract Presentations I -
Chairs
Kyeremeh Atuahene
Ghana
Catherine Hankins
Canada / The Netherlands
12:00
Male Engagement Optimization in Antenatal Care Clinics to Assess Need for Pre-Exposure Prophylaxis in Serodiscordant Couples: Estimation Based on Preliminary Data from a Cluster Randomized Trial in Zambézia Province, Mozambique
Caroline De Schacht
#9
12:03
Healthcare Providers’ Attitudes and Experiences Delivering Oral PrEP to Adolescent Girls and Young Women: Implementation Research to Inform PrEP Rollout in Kenya, South Africa, and Zimbabwe
Definate Nhamo
#10
12:06
Continuity of PrEP Use and Reasons for Discontinuation: A Cohort Study in a General Eswatini Population
Shreoshee Mukherjee
#11
12:09
PrEP Uptake and Various Referral Channels in Kenya: CrossSectional Analysis of a Large Scale Program
Micah Anyona
#12
12:12
Shifts in HIV Risk Outcomes among Adolescent Girls and Young Women (AGYW): Mixed Effects of DREAMS Interventions in Kenya
Jerry Okoth Okal
#13
12:15
Audience Q&A
12:30
Lunch and Early-career Investigator Meet-the-expert
SYMPOSIUM II - Johnson & Johnson: Optimising Treatment for Life-long Management of HIV -
Chair
Kwasi Torpey
Ghana
13:30
Welcome, Introduction, and Objectives WHO Technical Update and 2018 Guidelines
Kwasi Torpey
University of Ghana College of Health Sciences, Ghana
13:40
Faculty Discussion: Understanding the Role of PIs in Antiretroviral Treatment in Africa, Led by Kwasi Torpey
14:20
Case Study 1: Second-line Treatment Selecting a PI in second line in clinical practice in Africa
Michelle Moorhouse
University of Witwatersrand / Charlotte Maxeke Academic Hospital, South Africa
14:35
Case Study 2: Third-line Treatment Switching to a PI in third line in clinical practice in Africa
Lloyd Mulenga
University Teaching Hospital / University of Zambia School of Medicine, Zambia
14:50
New Horizons Advancing Pediatric HIV Care Initiative
Serge Paul Eholie
Treichville University Teaching Hospital, Côte d’Ivoire
Faculty Discussion: Implementing New Horizons in Africa
Led by Lloyd Mulenga
-
Closing
Kwasi Torpey
University of Ghana College of Health Sciences, Ghana
15:00
Refreshment Break and Poster Viewing
SYMPOSIUM III - Joep Lange Institute: Winners for Africa -
Chair
Tobias Rinke de Wit
The Netherlands
15:30
Welcome and Introduction
Tobias Rinke de Wit
Joep Lange Institute, the Netherlands
15:35
Using Single Cell RNAseq to Unravel Unconventional T-cell Responses
Shaheed Abdulhaqq
Oregon Health and Science University, Vaccine and Gene Therapy Institute, United States
15:40
Immune Activation and Depression in HIV Infection
Jonathan Chang
Duke University School of Medicine, United States
15:45
Epidemiology and Control of STIs in the Era of PrEP
Michael Traeger
Burnet Institute, Australia
15:50
Towards an HIV Risk Profile for Zambian Female Sex Workers
Kalonde Malama
Aix-Marseille University, France
15:55
Embracing Innovation in HIV Pediatric Diagnostics: A Win for Africa
Francis Matthew Simmonds
Elizabeth Glaser Pediatric AIDS Foundation, Zimbabwe
16:00
Discussion
16:25
Closing
Tobias Rinke de Wit
Joep Lange Institute, The Netherlands
Session 8: Emerging and Re-emerging Pathogens -
Chairs
Peter Kilmarx
USA
Elly Katabira
Uganda
16:30
Research Preparedness for Viral Haemorrhagic Fevers in West Africa: The Lassa Fever Example
Adebola Olayinka, MD, PhD
Nigeria Centre for Disease Control, Nigeria
16:50
Update on the DRC Ebola Outbreak
Ibrahima-Socé Fall, MD, MPH, MSc, PhD, FFPH
World Health Organization, Republic of the Congo
16:10
Discussion
17:20
Audience Q&A
DAY 3 - Thursday, 16 May 2019
- 07:00
07:00
Parallel Early Morning Sessions: Grantspersonship, Joep Lange Career Guidance, and Themed Poster Discussions
Session 9: Treatment -
Chairs
Margaret Lartey
Ghana
Mauro Schechter
Brazil
08:00
HIV Drug Resistance
Raquel Viana, PhD
Molecular Pathology Department for Lancet oratories, South Africa
08:25
Audience Q&A
08:30
Treatment Strategies from a Public Health Perspective
Meg Doherty, MD, MPH, PhD
World Health Organisation, Switzerland
08:55
Audience Q&A
Mini-Oral Abstract Presentations II -
Chairs
Elly Katabira
Uganda
Timothy Mastro
USA
09:00
Treatment Outcome among Patients on ART in Southern Tanzania: Does Time of ART Initiation Matter?
Bernadeta Msongole
#14
09:03
Pregnancy and Infant Outcomes among HIV-positive Women on Dolutegravir Versus Efavirenz-based Antiretroviral Therapy: Week 48 Analysis of the ADVANCE Trial
Nomathemba Chandiwana
#15
09:06
HIV Multi-class Resistance in Patients Failing to First and SecondLine ART in Resources Limited Setting, Mali
Almoustapha Issiaka Maiga
#16
09:09
Can Genotyping after Second-line ART Failure Reduce the Need for DRV/r-Based Third-Line ART in Kenya?
Dorothy Mwagae
#17
09:12
Self-reported HIV-positive Status but Subsequent HIV-negative Test Results in Population-Based HIV Impact Assessment (PHIA) Survey Participants – 11 Sub-Saharan African Countries, 2015-2017
Naeemah Logan
#18
09:15
Audience Q&A
SYMPOSIUM IV: ViiV - Scientific Debate: 2DR is the Next Frontier in HIV Treatment -
Chair
Michael Aboud
United Kingdom
09:30
ViiV - Scientific Debate
Joseph Oliver-Commey
Ghana Health Service, Ghana
Michelle Moorhouse
University of Witwatersrand / Charlotte Maxeke Academic Hospital, South Africa
Francois Venter
University of Witwatersrand, South Africa
Frank Post
King’s College Hospital NHS Foundation Trust, United Kingdom
10:30
Refreshment Break and Poster Viewing
SYMPOSIUM V: Abbvie: Journey towards Bridging the Gap in Monitoring HIV Viral Load in Resource-Limited Settings: The Third 90 Experiences in Kenya, Nigeria, and Zambia. -
Chair
David Kalombo
South Africa
11:00
Opening Remarks and Introduction of Speakers
David Kalombo
Foundation for Professional Development, South Africa
11:05
The Third 90 Experiences in Zambia
Lloyd Mulenga
Ministry of Health, Zambia
11:20
The Third 90 Experiences in Kenya
Maureen Kimani
National AIDS & STI Control Programme, Kenya
11:35
The Third 90 Experiences in Nigeria
Hadiza Khamofu
FHI360, Nigeria
11:50
Discussion & Closing
David Kalombo
Foundation for Professional Development, South Africa
Mini-Oral Abstract Presentations III -
Chairs
Elizabeth Bukusi
Kenya
Linda-Gail Bekker
South Africa
12:00
Addressing Barriers to Effective Scale Up of Viral Load Uptake: the Case of Viral Load Sample Rejection Rates in Five Counties in Kenya
Romeo Kithuka
#19
12:03
Effect of Strategic Index Case Testing on HIV Case Detection in Nigeria: APIN Experience
Scott Adamu
#20
12:06
Reaching the Unreachable: Early Results from Index Testing in Zambia in the CIRKUITS Project
Linah K. Mwango
#21
12:09
Maximizing HIV Testing Yield Through Index Partner Testing Using Assisted Partner Notification (APN) Approach: Implementation Progress in Uganda
John Bosco Junior Matovu
#22
12:12
Partner Delivered HIV Self-Testing is Highly Acceptable and Facilitates Linkage to Care for Partners of HIV Index and Antenatal Care Clients in South Africa
Vincent Zishiri
#23
12:15
Audience Q&A
12:30
Lunch and Early-career Investigator Meet-the-expert
Session 10: Laboratory Science at the Service of the Response -
Chairs
Stephen Ayisi Addo
Ghana
Charles Boucher
The Netherlands
13:30
Laboratory QA and Innovation
Pascale Ondoa, MD, MSc, PhD
African Society of Laboratory Medicine, The Netherlands
13:55
Audience Q&A
SYMPOSIUM VI: International AIDS Society (IAS): Differentiated Service Delivery in West and Central Africa – From Pilots to Policy -
Chairs
Ndoungou Salla Ba
Burkina Faso
Linda-Gail Bekker
South Africa
Welcome and Introduction
Ndoungou Salla Ba
World Health Organization, Burkina Faso
Linda-Gail Bekker
Desmond Tutu HIV Foundation / University of Cape Town, South Africa
14:00
Providing Community ART in a Time of Conflict: Pilot Projects from Central African Republic
Charles Ssonko
Médecins Sans Frontières, United Kingdom
14:10
Patient Preference: Scaling up PODIs, Fast-track, and ART Refills in Peer Support Groups in the Democratic Republic of the Congo
Didier Kamerhe
PATH, Democratic Republic of the Congo
14:20
Pushing ART Refills to Six Months: National Policy Progress in Guinea
Foromo Guilavogui
Ministry of Health, Guinea
14:30
Putting the Policy into Practice: The Experience of DSD Guidance in Ghana
Nyonuku Akosua Baddoo
Ministry of Health, Ghana
14:40
Discussion and Launch of Key Messaging Document on DSD in WCA
Ndoungou Salla Ba and Linda-Gail Bekker
-
15:00
Refreshment Break and Poster Viewing
Mini-Oral Abstract Presentations IV -
Chairs
Stephen Watiti
Uganda
15:30
Improved Case Detection and Management of Advanced HIV Disease through TB Contact Risk Stratification and Implementation of a Package of Interventions in a Rural District of Mozambique
Santiago Izco
#24
15:33
“From Ostracism to Centralism” The Evolution of Meaningful Involvement of People Living with HIV (MIPA) in Zimbabwe Resulting in Improved Health Outcomes
Silibele Mpofu
#25
15:36
Évaluation de l’Efficacité Virologique et Clinique de la Prise en Charge Thérapeutiques des Enfants VIH+ dans les Régions Sud du Sénégal (EnPRISE2)
Aminata Niang
#26
15:39
Mortality and Virologic Outcomes between Two to Five Years of Age after Early Initiation during Infancy of Antiretroviral Treatment: Experience of the ANRS-1240 Pediacam Study (Cameroon)
Francis Ateba Ndongo
#27
15:42
Point-of-Care Early Infant Diagnostic Testing at Alternative Entry Points: a High-Yield, Cost-Efficient Strategy to Increase HIV Positive Infant Case Finding
Isaac Ssewanyana
#28
15:45
Audience Q&A
Session 11: Paediatrics: Leaving No One Behind -
Chair
Lorna Renner
Ghana
16:00
Stepping on the Accelerator: Innovations in Pediatric HIV Programming
Nadia A. Sam-Agudu, MD, CTropMed
Institute of Human Virology/ University of Maryland School of Medicine, Nigeria / USA
16:25
Audience Q&A
Session 12: Non-Communicable Disease -
Chairs
Kyeremeh Atuahene
Ghana
Pierre-Marie Girard
France
16:30
Burden of Disease, Prevention Strategies, Treatment Studies, Service Intergration
Gerald Yonga, MBChB, MMed, FRCP, MBA, FESC, FACC
Aga Khan University Hospital, Kenya
16:55
Audience Q&A
Session 13: Women in Science, Medicine, and Global Health -
Chair
Catherine Hankins
Canada / The Netherlands
17:00
Advancing Women: What Do We Need to Do and How?
Helen Rees, MD, MA, MRCGP
The WITS Reproductive Health and HIV Institute (WRHI), University of the Witwatersrand, South Africa
17:25
Audience Q&A
Day 4 - Friday, 17 May 2019
- 07:00
07:00
Parallel Early Morning Sessions: Grantspersonship, Joep Lange Career Guidance, and Themed Poster Discussions
Mini-Oral Abstract Presentations V -
Chairs
Margaret Lartey
Ghana
Pierre-Marie Girard
France
08:00
Examining the Effectiveness of Differentiated Service Delivery Models for HIV Testing among Female Sex Workers in Ghana
David Tetteh Nartey
#29
08:03
Sexual and Mental Health of Transgender Persons in Nairobi, Kenya
Rodah Wanjiru
#30
08:06
Analyse Coût-Efficacité d’une Stratégie Thérapeutique à Base de Sofosbuvir dans le Traitement de l’Hépatite C en Afrique Centrale et de l’Ouest (ANRS 12311)
Maël Baudoin
#31
08:09
Improved HIV Testing Efficiency in Zambia through Enhanced Real-time Program Surveillance
Andres Montaner
#32
08:12
Reasons for PrEP Decline among Clients Identified at Substantial Risk for HIV Infection in the Kingdom of Eswatini
Sindy Matse
#33
08:15
Audience Q&A
Session 14： Update on Tuberculosis -
Chair
Elly Katabira
Uganda
08:30
State of the Response, New Drugs and Diagnostics, Vaccine Developments, Advocacy, and Lessons Learned from UN General Assembly on TB
Kogieleum Naidoo, MBChB, PhD
Centre for the AIDS Programme of Research in South Africa, South Africa
09:00
SYMPOSIUM VII: Roche - Debate: Patient Self- Management - Radical patient self-management will address current health challenges in Africa
Chair: Catherine Hankins
Canada / The Netherlands
Francois Venter
University of Witwatersrand, South Africa
Sindisiwe Van Zyl
Private Practice, South Africa
Sergio Carmona
Charlotte Maxeke Academic Hospital, South Africa
Tendani Gaolathe
Ministry of Health, Botswana
10:00
Refreshment Break and Poster Viewing
Session 15： Science in Action -
Chair
Peter Kilmarx
USA
10:30
The Importance of Science and Innovation for the Global Fund
Christoph Benn
Global Fund, Switzerland
10:55
Audience Q&A
Session 16: Ethics of Choice in Public Sector Programmes, Including Access to Contraception -
Chair
Timothy Mastro
USA
11:00
Three Billboards on West African Adolescent HIV Prevention Studies: Rights, Complexities and Possible Solutions
Ann Strode, BA, LLB, LLM, PhD
University of KwaZulu-Natal, South Africa
11:25
Audience Q&A
Mini-Oral Abstract Presentations VI -
Chairs
Lorna Renner
Ghana
Anna Laura Ross
Switzerland
11:30
Factors Associated with Liver Injury among HIV Infected Children and Adolescents Attending a National Referral Pediatric HIV Clinic in Uganda
Bonny Mulindwa
#34
11:33
Prevalence of Cervical HPV Infection among Women Living with HIV in Harare, Zimbabwe
Ardele Maureen Mandiriri
#35
11:36
Application of Machine Learning Models in Prediction of PrEP Retention among High-risk Persons in Uganda
Agnes Kiragga
#36
11:39
Economic Burden of Accessing Treatment on People Living with HIV; Outcomes of a Cross-Sectional Survey in Lagos State, Nigeria
Adewale Ogunnaike
#37
11:42
Characterizing the HIV Epidemic among 15-24 Year Olds in Urban Ethiopia, 2017-18
Aderonke Ajiboye
#38
11:45
Audience Q&A
Session 17: Closing Session -
Chairs
Kwasi Torpey
Ghana
Elly Katabira
Uganda
Catherine Hankins
Canada / The Netherlands
12:00
Presentation of the Joep Lange Award to Highest Scoring Abstract by an Early-Career African Scientist
12:10
Reflections by the Chairs of the 13th INTEREST Conference
12:20
Closure of the Conference
Overview
Welcome
The annual INTEREST Conference is the premier scientific conference for HIV in Africa and brings together scientists involved in HIV treatment, pathogenesis, and prevention research from around the world. The conference will showcase cutting-edge knowledge in the diagnosis and treatment of HIV and the prevention of the HIV-1 infection. Additionally, it will continue to foster building a community of African physicians and scientists to facilitate the implementation of local solutions for the management of patients living with HIV-1 infection and for the prevention of HIV transmission.
Practical Information
Accommodation
Accommodation is not part of the registration fee.
Badges
We kindly request all participants to wear the conference badge at all times during the 13th Interest Conference.
Certificate of Attendance
A Certificate of Attendance in PDF format will be emailed to you in the week following the conference.
Conference materials
Conference materials will be handed out upon registration.
Language
The official conference language will be English. Simultaneous translation will be available (French & Portuguese).
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this conference, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this conference. The Scientific Secretariat of this conference, the Amsterdam Institute for Global Health and Development, cannot accept any liability for the logistical arrangements made for this conference or any risks associated with them.
Insurance and Liability
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. It is highly recommended that all participants carry proper individual travel and health insurance, as Virology Education, AIGHD and the INTEREST conference cannot accept liability for accidents, illness, or injuries that may occur at or during the conference.
Photographs, audio, and video recording
Recording of official meeting sessions either via camera, smartphone, or other audio/video recording devices is not permitted without explicit consent of a speaker. Otherwise, only the official medical writers appointed by the INTEREST conference organisers may make recordings. Presentations will be posted on our INTEREST conference website as soon as possible after the conference if the speaker has given the organisers permission to do so.
Language
Related Programs
